Vaduganathan, M., Claggett, B., Packer, M., McMurray, J. J. V., Rouleau, J., Zile, M., … Solomon, S. (2018). NATRIURETIC PEPTIDES AS PREDICTIVE BIOMARKERS OF TREATMENT RESPONSE IN CLINICAL TRIALS OF HEART FAILURE. Journal of the American College of Cardiology, 71(11), A873–A873. https://doi.org/10.1016/s0735-1097(18)31414-1

Vaduganathan, Muthiah, Brian Claggett, Milton Packer, John J. V. McMurray, Jean Rouleau, Michael Zile, Karl Swedberg, and Scott Solomon. “NATRIURETIC PEPTIDES AS PREDICTIVE BIOMARKERS OF TREATMENT RESPONSE IN CLINICAL TRIALS OF HEART FAILURE.” Journal of the American College of Cardiology 71, no. 11 (March 2018): A873–A873. https://doi.org/10.1016/s0735-1097(18)31414-1.

Vaduganathan M, Claggett B, Packer M, McMurray JJV, Rouleau J, Zile M, et al. NATRIURETIC PEPTIDES AS PREDICTIVE BIOMARKERS OF TREATMENT RESPONSE IN CLINICAL TRIALS OF HEART FAILURE. Journal of the American College of Cardiology. 2018 Mar;71(11):A873–A873.

Vaduganathan, Muthiah, et al. “NATRIURETIC PEPTIDES AS PREDICTIVE BIOMARKERS OF TREATMENT RESPONSE IN CLINICAL TRIALS OF HEART FAILURE.” Journal of the American College of Cardiology, vol. 71, no. 11, Elsevier BV, Mar. 2018, pp. A873–A873. Crossref, doi:10.1016/s0735-1097(18)31414-1.

Vaduganathan M, Claggett B, Packer M, McMurray JJV, Rouleau J, Zile M, Swedberg K, Solomon S. NATRIURETIC PEPTIDES AS PREDICTIVE BIOMARKERS OF TREATMENT RESPONSE IN CLINICAL TRIALS OF HEART FAILURE. Journal of the American College of Cardiology. Elsevier BV; 2018 Mar;71(11):A873–A873.